Prime Therapeutics employees seek professional and personal development with Women’s Health Leadership TRUST membership

Network supports growth, well-being and success of members throughout their leadership journey

July 27, 2022

Prime Therapeutics (Prime) selected five employees for a company-sponsored membership with the Women’s Health Leadership TRUST (the TRUST) based on their leadership attributes, dedication to the health care industry and commitment to advancing women in health care.

Christine Bent, senior vice president and chief operating officer at Prime, serves as the immediate past president on the TRUST’s board of directors. The organization’s mission is to be an inclusive, diverse and collaborative network that advocates, inspires and offers insights to women leaders in health care.

“The TRUST is a great way for women to foster their leadership skills and continue to grow,” Bent said. “It’s exciting that Prime with our Diversity & Inclusion (D&I) Council are giving these employees a development opportunity that contributes to the advancement of women in health care.”

Prime employees new to the TRUST may take advantage of member benefits including networking, professional and personal development and ongoing education and events. Other opportunities include a mentoring program and volunteer committee participation.

Recipients of a one-year membership were nominated by their peers. Member selection was finalized by a review panel of Prime executive and D&I Council leaders.

Prime’s newest members of the TRUST will join the over 400 members that continue to draw on the vision to “Create new possibilities for all women – in health care, well-being and beyond.”

Find out more about Christine’s passion for fostering an environment of sponsorship and the work of the TRUST.

Related news


May 15, 2024

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs


May 14, 2024

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended


May 14, 2024

Prime/MRx releases its first corporate social responsibility report

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey